Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2294-2300

  Yang, Xilin ^a   Ko, Gary T C ^a   So, Wing Yee ^a   Ronald, C W ^a   Kong, Alice P S ^a   Lam, Christopher W K ^a   Ho, Chung Shun ^a   Chow, Chun Chung ^a   Tong, Peter C Y ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SMOKING;

ADULT; AGED; ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HONG KONG; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; STROKE;

EID: 64349101448     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1079     Document Type: Article

References (24)

1. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431, 2004
2. Niskanen L, Turpeinen A, Penttila I, Uus- itupa MI: Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21: 1861-1869, 1998
3. Nathan DM, Cleary PA, Backlund JY, Ge- nuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653, 2005
4. Huang ES, Meigs JB, Singer DE: The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 111:633-642, 2001
5. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
6. Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559, 2008
7. Hoffmann K, Heidemann C, Weikert C, Schulze MB, Boeing H: Estimating the proportion of disease due to classes of sufficient causes. Am J Epidemiol 163:76-83, 2006
8. Ahlbom A, Alfredsson L: Interaction: a word with two meanings creates confusion. Eur J Epidemiol 20:563-564, 2005
9. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A: Calculating measures of biological interaction. Eur J Epidemiol 20:575-579, 2005
10. Yang XL, So WY, Kong AP, Ho CS, Lam CW, Stevens RJ, Lyu RR, Yin DD, Cock-ram CS, Tong PC, Wong V, Chan JC: Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 30:65-70, 2007
11. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
12. Yang X, So WY, Tong PC, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Chan JC: Development and validation of an all-cause mortality risk score in type 2 diabetes: The Hong Kong Diabetes Registry. Arch Intern Med 168:451-457, 2008
13. Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho CS, Cockram CS, Wong VC, Tong PC, Chan JC: Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients: the Hong Kong diabetes registry. Cardiovasc Diabetol 6:37, 2007
14. So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC: Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes: The Hong Kong Diabetes Registry. Diabete Metab Res Rev 24:238-246, 2007
15. Piwernetz K, Home PD, Snorgaard O, An- tsiferov M, Staehr-Johansen K, Krans M, for the Diabetes Care Monitoring Group of the St. Vincent Declaration Steering Committee: Monitoring the targets of the St. Vincent Declaration and the implementation of quality management in diabetes care: the Diabetes Care initiative. Diabet Med 10:371-377, 1993
16. Ma YC, Zuo L, ChenJH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937-2944, 2006
17. Harrell F: Regression Modelling Strategies with applications to Linear Models, Logistic Regression, and Survival Analysis. New York, Springer-Varlag, 2001
18. Kalilani L, Atashili J: Measuring additive interaction using odds ratios. Epidemiol Perspect Innov 3:5, 2006
19. Li R, Chambless L: Test for additive interaction in proportional hazards models. Ann Epidemiol 17:227-236, 2007
20. Yang X, Kong AP, So WY, Ma RC, Ho CS, Lam CW, Chow CC, Cockram CS, Tong PC, Chan JC: Effects of chronic hyperglycaemia on incident stroke in Hong Kong Chinese patients with type 2 diabetes. Diabete Metab Res Rev 23:220-226, 2007
21. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48: 17-26, 2005
22. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
23. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572, 2008
24. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study. Lancet 355:253-259, 2000